Evidence map›Paper›PMID 38361123›Full record

ArticleNature medicine2024

Effectiveness and safety of telehealth medication abortion in the USA.

Ushma D Upadhyay, Leah R Koenig, Karen Meckstroth, Jennifer Ko, Ena Suseth Valladares, M Antonia Biggs

Open access · hybridAbstract read
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
31.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. The use of telemedicine services for medical abortion.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A Pediatric- and Adolescent-Focused Medication Abortion Curriculum for Multidisciplinary Trainees.MedEdPORTAL : the journal of teaching and learning resources · 2025
    Article
  18. Article
  19. Article
  20. Pricing of medication abortion in the United States, 2021-2023.Perspectives on sexual and reproductive health · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ushma D UpadhyayDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA. ushma.upadhyay@ucsf.edu.ORCID 0000-0002-2731-2157
Leah R KoenigDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
Karen MeckstrothDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
Jennifer KoDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
Ena Suseth ValladaresCalifornia Latinas for Reproductive Justice, Los Angeles, CA, USA.
M Antonia BiggsDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, USA.
University of California, San Francisco · USCalifornia Latinas for Reproductive Justice · US

Funding

UCSF Data Science Training to Advance Behavioral and Social Science Expertise for Health Research (DaTABASE) ProgramT32MD015070 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI William Brown III, Yulin Hswen · 2020 to 2026
$1.7M
Protocols to ascertain adverse events after telehealth sexual and reproductive health servicesF31HD111277 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOENIG, LEAH REN-AI · 2023 to 2024
$81k
NICHD NIH HHS F31 HD111277NIMHD NIH HHS T32 MD015070
6 · The paper itself

Abstract

Telehealth abortion has become critical to addressing surges in demand in states where abortion remains legal but evidence on its effectiveness and safety is limited. California Home Abortion by Telehealth (CHAT) is a prospective study that follows pregnant people who obtained medication abortion via telehealth from three virtual clinics operating in 20 states and Washington, DC between April 2021 and January 2022. Individuals were screened using a standardized no-test protocol, primarily relying on their medical history to assess medical eligibility. We assessed effectiveness, defined as complete abortion after 200 mg mifepristone and 1,600 μg misoprostol (or lower) without additional intervention; safety was measured by the absence of serious adverse events. We estimated rates using multivariable logistic regression and multiple imputation to account for missing data. Among 6,034 abortions, 97.7% (95% confidence interval (CI) = 97.2-98.1%) were complete without subsequent known intervention or ongoing pregnancy after the initial treatment. Overall, 99.8% (99.6-99.9%) of abortions were not followed by serious adverse events. In total, 0.25% of patients experienced a serious abortion-related adverse event, 0.16% were treated for an ectopic pregnancy and 1.3% abortions were followed by emergency department visits. There were no differences in effectiveness or safety between synchronous and asynchronous models of care. Telehealth medication abortion is effective, safe and comparable to published rates of in-person medication abortion care.

Indexed as

Abortion, InducedAbortion, SpontaneousMisoprostolTelemedicineFemaleHumansMifepristonePregnancyProspective StudiesUnited StatesMifepristoneMisoprostol

Identifiers

PMID38361123
PMCPMC11031403
OpenAlexW4391845449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.